Viscofan, S.A.

BME:VIS Voorraadrapport

Marktkapitalisatie: €2.8b

Viscofan Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Viscofan heeft een totaal eigen vermogen van €932.5M en een totale schuld van €243.1M, wat de schuld-eigenvermogensverhouding op 26.1% brengt. De totale activa en totale passiva bedragen respectievelijk €1.4B en €475.5M. De EBIT Viscofan is €197.5M waardoor de rentedekking 48.4 is. Het heeft contanten en kortetermijnbeleggingen van €64.7M.

Belangrijke informatie

26.1%

Verhouding schuld/eigen vermogen

€243.11m

Schuld

Rente dekkingsratio48.4x
Contant€64.67m
Aandelen€932.49m
Totaal verplichtingen€475.55m
Totaal activa€1.41b

Recente financiële gezondheidsupdates

Is Viscofan (BME:VIS) Using Too Much Debt?

Dec 21
Is Viscofan (BME:VIS) Using Too Much Debt?

Viscofan (BME:VIS) Has A Pretty Healthy Balance Sheet

Sep 20
Viscofan (BME:VIS) Has A Pretty Healthy Balance Sheet

Here's Why Viscofan (BME:VIS) Can Manage Its Debt Responsibly

May 25
Here's Why Viscofan (BME:VIS) Can Manage Its Debt Responsibly

Is Viscofan (BME:VIS) Using Too Much Debt?

Jan 07
Is Viscofan (BME:VIS) Using Too Much Debt?

Viscofan (BME:VIS) Has A Pretty Healthy Balance Sheet

Sep 01
Viscofan (BME:VIS) Has A Pretty Healthy Balance Sheet

Does Viscofan (BME:VIS) Have A Healthy Balance Sheet?

Mar 25
Does Viscofan (BME:VIS) Have A Healthy Balance Sheet?

Recent updates

Viscofan (BME:VIS) Shareholders Will Want The ROCE Trajectory To Continue

Dec 26
Viscofan (BME:VIS) Shareholders Will Want The ROCE Trajectory To Continue

Analyst Estimates: Here's What Brokers Think Of Viscofan, S.A. (BME:VIS) After Its Third-Quarter Report

Oct 26
Analyst Estimates: Here's What Brokers Think Of Viscofan, S.A. (BME:VIS) After Its Third-Quarter Report

Estimating The Fair Value Of Viscofan, S.A. (BME:VIS)

Oct 08
Estimating The Fair Value Of Viscofan, S.A. (BME:VIS)

Viscofan, S.A.'s (BME:VIS) Popularity With Investors Is Under Threat From Overpricing

Sep 25
Viscofan, S.A.'s (BME:VIS) Popularity With Investors Is Under Threat From Overpricing

Here's Why We Think Viscofan (BME:VIS) Might Deserve Your Attention Today

Aug 17
Here's Why We Think Viscofan (BME:VIS) Might Deserve Your Attention Today

Viscofan, S.A. (BME:VIS) Interim Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Aug 02
Viscofan, S.A. (BME:VIS) Interim Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Viscofan (BME:VIS) Shareholders Will Want The ROCE Trajectory To Continue

Jun 26
Viscofan (BME:VIS) Shareholders Will Want The ROCE Trajectory To Continue

Viscofan, S.A. (BME:VIS) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Apr 20
Viscofan, S.A. (BME:VIS) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Why We Think Viscofan, S.A.'s (BME:VIS) CEO Compensation Is Not Excessive At All

Apr 11
Why We Think Viscofan, S.A.'s (BME:VIS) CEO Compensation Is Not Excessive At All

Is There An Opportunity With Viscofan, S.A.'s (BME:VIS) 38% Undervaluation?

Apr 04
Is There An Opportunity With Viscofan, S.A.'s (BME:VIS) 38% Undervaluation?

Some Shareholders Feeling Restless Over Viscofan, S.A.'s (BME:VIS) P/E Ratio

Mar 18
Some Shareholders Feeling Restless Over Viscofan, S.A.'s (BME:VIS) P/E Ratio

Slowing Rates Of Return At Viscofan (BME:VIS) Leave Little Room For Excitement

Jan 17
Slowing Rates Of Return At Viscofan (BME:VIS) Leave Little Room For Excitement

Is Viscofan (BME:VIS) Using Too Much Debt?

Dec 21
Is Viscofan (BME:VIS) Using Too Much Debt?

Is There An Opportunity With Viscofan, S.A.'s (BME:VIS) 37% Undervaluation?

Nov 15
Is There An Opportunity With Viscofan, S.A.'s (BME:VIS) 37% Undervaluation?

Viscofan (BME:VIS) Has A Pretty Healthy Balance Sheet

Sep 20
Viscofan (BME:VIS) Has A Pretty Healthy Balance Sheet

Returns On Capital At Viscofan (BME:VIS) Have Stalled

Aug 29
Returns On Capital At Viscofan (BME:VIS) Have Stalled

Is There An Opportunity With Viscofan, S.A.'s (BME:VIS) 32% Undervaluation?

Aug 11
Is There An Opportunity With Viscofan, S.A.'s (BME:VIS) 32% Undervaluation?

Here's Why Viscofan (BME:VIS) Can Manage Its Debt Responsibly

May 25
Here's Why Viscofan (BME:VIS) Can Manage Its Debt Responsibly

Viscofan's (BME:VIS) Dividend Will Be Increased To €0.4374

May 04
Viscofan's (BME:VIS) Dividend Will Be Increased To €0.4374

Here's Why We Think Viscofan (BME:VIS) Is Well Worth Watching

Apr 24
Here's Why We Think Viscofan (BME:VIS) Is Well Worth Watching

The Returns At Viscofan (BME:VIS) Aren't Growing

Mar 02
The Returns At Viscofan (BME:VIS) Aren't Growing

Estimating The Intrinsic Value Of Viscofan, S.A. (BME:VIS)

Feb 16
Estimating The Intrinsic Value Of Viscofan, S.A. (BME:VIS)

Is Viscofan (BME:VIS) Using Too Much Debt?

Jan 07
Is Viscofan (BME:VIS) Using Too Much Debt?

Returns On Capital At Viscofan (BME:VIS) Have Stalled

Nov 29
Returns On Capital At Viscofan (BME:VIS) Have Stalled

Viscofan, S.A.'s (BME:VIS) Intrinsic Value Is Potentially 77% Above Its Share Price

Nov 11
Viscofan, S.A.'s (BME:VIS) Intrinsic Value Is Potentially 77% Above Its Share Price

Viscofan (BME:VIS) Has A Pretty Healthy Balance Sheet

Sep 01
Viscofan (BME:VIS) Has A Pretty Healthy Balance Sheet

Viscofan (BME:VIS) Has Some Way To Go To Become A Multi-Bagger

Aug 03
Viscofan (BME:VIS) Has Some Way To Go To Become A Multi-Bagger

Viscofan's (BME:VIS) Returns Have Hit A Wall

May 03
Viscofan's (BME:VIS) Returns Have Hit A Wall

Does Viscofan (BME:VIS) Have A Healthy Balance Sheet?

Mar 25
Does Viscofan (BME:VIS) Have A Healthy Balance Sheet?

Is Viscofan, S.A. (BME:VIS) Trading At A 38% Discount?

Mar 06
Is Viscofan, S.A. (BME:VIS) Trading At A 38% Discount?

Here's Why We Think Viscofan (BME:VIS) Is Well Worth Watching

Jan 15
Here's Why We Think Viscofan (BME:VIS) Is Well Worth Watching

Returns At Viscofan (BME:VIS) Appear To Be Weighed Down

Dec 29
Returns At Viscofan (BME:VIS) Appear To Be Weighed Down

Viscofan (BME:VIS) Has A Rock Solid Balance Sheet

Nov 24
Viscofan (BME:VIS) Has A Rock Solid Balance Sheet

Is Viscofan, S.A. (BME:VIS) Trading At A 24% Discount?

Oct 10
Is Viscofan, S.A. (BME:VIS) Trading At A 24% Discount?

With EPS Growth And More, Viscofan (BME:VIS) Is Interesting

Sep 23
With EPS Growth And More, Viscofan (BME:VIS) Is Interesting

Returns On Capital At Viscofan (BME:VIS) Have Stalled

Aug 19
Returns On Capital At Viscofan (BME:VIS) Have Stalled

Viscofan (BME:VIS) Has A Rock Solid Balance Sheet

Aug 03
Viscofan (BME:VIS) Has A Rock Solid Balance Sheet

A Look At The Fair Value Of Viscofan, S.A. (BME:VIS)

May 17
A Look At The Fair Value Of Viscofan, S.A. (BME:VIS)

Viscofan (BME:VIS) Could Easily Take On More Debt

Apr 07
Viscofan (BME:VIS) Could Easily Take On More Debt

Should We Be Excited About The Trends Of Returns At Viscofan (BME:VIS)?

Mar 04
Should We Be Excited About The Trends Of Returns At Viscofan (BME:VIS)?

Here's What Viscofan, S.A.'s (BME:VIS) Shareholder Ownership Structure Looks Like

Feb 17
Here's What Viscofan, S.A.'s (BME:VIS) Shareholder Ownership Structure Looks Like

Viscofan, S.A.'s (BME:VIS) Stock Has Shown A Decent Performance: Have Financials A Role To Play?

Feb 02
Viscofan, S.A.'s (BME:VIS) Stock Has Shown A Decent Performance: Have Financials A Role To Play?

A Look At The Intrinsic Value Of Viscofan, S.A. (BME:VIS)

Jan 18
A Look At The Intrinsic Value Of Viscofan, S.A. (BME:VIS)

Why Viscofan's (BME:VIS) CEO Pay Matters

Dec 26
Why Viscofan's (BME:VIS) CEO Pay Matters

Income Investors Should Know That Viscofan, S.A. (BME:VIS) Goes Ex-Dividend Soon

Dec 13
Income Investors Should Know That Viscofan, S.A. (BME:VIS) Goes Ex-Dividend Soon

Should Viscofan, S.A. (BME:VIS) Be Part Of Your Dividend Portfolio?

Dec 04
Should Viscofan, S.A. (BME:VIS) Be Part Of Your Dividend Portfolio?

The Returns At Viscofan (BME:VIS) Provide Us With Signs Of What's To Come

Nov 19
The Returns At Viscofan (BME:VIS) Provide Us With Signs Of What's To Come

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( €793.1M ) VIS } overtreffen de korte termijn passiva ( €336.8M ).

Langlopende schulden: De kortetermijnactiva VIS ( €793.1M ) overtreffen de langetermijnschulden ( €138.7M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 19.1% ) VIS wordt als voldoende beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van VIS is de afgelopen 5 jaar gestegen van 20.7% naar 26.1%.

Schuldendekking: De schuld van VIS wordt goed gedekt door de operationele kasstroom ( 87.5% ).

Rentedekking: De rentebetalingen op de schuld van VIS worden goed gedekt door EBIT ( 48.4 x dekking).

Balans

Ontdek gezonde bedrijven

7D

1Y

7D

1Y

7D

1Y

Bedrijfsanalyse en status van financiële gegevens

GegevensLaatst bijgewerkt (UTC-tijd)
Bedrijfsanalyse2024/12/27 05:45
Aandelenkoers aan het einde van de dag2024/12/27 00:00
Inkomsten2024/09/30
Jaarlijkse inkomsten2023/12/31

Gegevensbronnen

De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.

PakketGegevensTijdframeVoorbeeld Amerikaanse bron *
Financiële gegevens bedrijf10 jaar
  • Resultatenrekening
  • Kasstroomoverzicht
  • Balans
Consensus schattingen analisten+3 jaar
  • Financiële prognoses
  • Koersdoelen analisten
Marktprijzen30 jaar
  • Aandelenprijzen
  • Dividenden, splitsingen en acties
Eigendom10 jaar
  • Top aandeelhouders
  • Handel met voorkennis
Beheer10 jaar
  • Leiderschapsteam
  • Raad van bestuur
Belangrijkste ontwikkelingen10 jaar
  • Bedrijfsaankondigingen

* voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige regelgevingsformulieren en bronnen gebruikt.

Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Lees hier meer.

Analysemodel en Snowflake

Details van het analysemodel dat is gebruikt om dit rapport te genereren, zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen voor het gebruik van onze rapporten en tutorials op Youtube.

Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.

Industrie en sector

Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op .

Bronnen van analisten

Viscofan, S.A. wordt gevolgd door 28 analisten. 10 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.

AnalistInstelling
César Sánchez-Grande BergonAhorro Corporación
José RitoBanco BPI, S.A.
Sofia Rebuelta VillegasBanco de Madrid S.A.U.